Linear V1-vascular vasopressin antagonists suitable for radioiodination, biotinylation, and fluorescent labeling.

Linear V1-vascular vasopressin antagonists suitable for radioiodination, biotinylation, and fluorescent labeling.
复制标题

线性 V1-血管加压素拮抗剂,适用于放射性碘标记、生物素化和荧光标记。

DOI:
10.1152/ajpendo.1993.265.6.e906
复制
发表时间:
1993
期刊:
The American journal of physiology
影响因子:
--
通讯作者:
Madhun,Z
Madhun,Z
中科院分区:
--
文献类型:
--
作者:
Thibonnier,M;Bayer,AL;Madhun,Z

文献摘要

被引文献

相似文献

我们修改了几个线性V1-血管精氨酸加压素(AVP)拮抗剂,以获得适合于放射性碘标记,生物素化和荧光标记的化合物。在与人血小板V1-血管AVP受体的结合竞争实验中,线性V1拮抗剂苯乙酰基-D-Tyr(Et)-Phe-Gln-Asn-Lys-Pro-Arg-NH 2(PhaaGln)显示出最大的亲和力[解离常数(Kd)= 0.05 +/- 0.01 nM]。放射性碘标记化合物苯乙酰基-D-Tyr(Et)-Phe-Val-Asn-Lys-Pro-125 I标记的Tyr-NH 2(125 I标记的TyrPhaa)的特征在于高亲和力(Kd = 1.42 +/- 0.19 nM)、低非特异性结合和良好的稳定性。PhaaGln偶联十二碳配体保留了对V1血管AVP受体的良好亲和力(Kd = 1.41 +/- 0.20 nM)。复合物PhaaGln-dodecabiotin-抗生物素蛋白是双功能的,因为抗生物素蛋白-琼脂糖柱特异性结合用125 I-TyrPhaa-dodecabiotin标记的V1-血管AVP受体。在A7 r5血管平滑肌细胞加载fura-2,PhaaGln和PhaaGln-dodecabiotin是纯拮抗剂,因为它们阻断AVP诱导的钙动员,但不引起钙信号本身。A7 r5血管平滑肌细胞的V1-血管AVP受体通过结合的PhaaGln-十二碳生物素可视化,所述结合的PhaaGln-十二碳生物素通过用荧光素抗生物素蛋白标记而发荧光。因此,线性V1-血管AVP拮抗剂可用作高亲和力和特异性放射性碘标记、生物素标记和荧光探针,以探索人和动物来源的V1-血管AVP受体。
We modified several linear V1-vascular arginine vasopressin (AVP) antagonists to obtain compounds suitable for radioiodination, biotinylation, and fluorescent labeling. In binding competition experiments with human platelet V1-vascular AVP receptors, the linear V1 antagonist phenylacetyl-D-Tyr(Et)-Phe-Gln-Asn-Lys-Pro-Arg-NH2 (PhaaGln) displayed the greatest affinity [dissociation constant (Kd) = 0.05 +/- 0.01 nM]. The radioiodinated compound phenylacetyl-D-Tyr(Et)-Phe-Val-Asn-Lys-Pro-125I-labeled Tyr-NH2 (125I-labeled TyrPhaa) was characterized by a high affinity (Kd = 1.42 +/- 0.19 nM), a low nonspecific binding, and good stability. PhaaGln coupled to dodecabiotin retained a good affinity for V1-vascular AVP receptors (Kd = 1.41 +/- 0.20 nM). The complex PhaaGln-dodecabiotin-avidin is bifunctional, since an avidin-agarose column specifically bound V1-vascular AVP receptors labeled with 125I-TyrPhaa-dodecabiotin. In A7r5 vascular smooth muscle cells loaded with fura-2, PhaaGln and PhaaGln-dodecabiotin were pure antagonists as they blocked AVP-induced calcium mobilization but did not elicit a calcium signal by themselves. V1-vascular AVP receptors of A7r5 vascular smooth muscle cells were visualized by bound PhaaGln-dodecabiotin made fluorescent by labeling with fluorescein avidin. Thus linear V1-vascular AVP antagonists can be used as high affinity and specificity radioiodinated, biotinylated, and fluorescent probes to explore V1-vascular AVP receptors of human and animal origin.